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1. INTRODUCTION 
 
 
1.1 Multiple endocrine neoplasia type 1 
 
Multiple endocrine neoplasia type-1 (MEN1) is an autosomal 
dominantly inherited disease caused by mutations in the Men1 
tumor suppressor gene. The main endocrine expressions of 
MEN1 are hormone hypersecretion due to clonal tumors of the 
parathyroids, enteropancreatic neuroendocrine tissue and 
anterior pituitary (Marx SJ, 2002). The main non hormonal 
manifestations of MEN1 are facial angiofibroma, lipoma, 
collagenoma, meningioma, and smooth muscle tumor. Men1 
mutations can contribute to hereditary and non hereditary 
tumors. Germline and somatic mutations are distributed over 
the entire Men1 encoding region, without mutations hot spots 
and no suggestion of a genotype-phenotype correlation (Wautot 
et al, 2002). 
Men1 gene was identified by positional cloning in 1997 and 
mapped to chromosome 11 (Chandrasekharappa S.C.et al, 
1997). The product of Men1, Menin, encodes a protein of 610 
amino acids residues (Chandrasekharappa S.C.et al, 1997).  
Menin harbors two nuclear localization signals at the C terminus 
and it has been detectec in the nucleus in different cell types 
(Guru S.C. et al., 1998) (Ikeo Y. et al., 1999) (Stewart C. et al., 
1998) but its subnuclear distribution is not yet clear. 
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1.2 Men1 is a tumor suppressor gene 
 
Kinzler and Vogelstein introduced the term ‘gatekeeper’ to 
describe a class of genes that directly control cellular 
proliferation and whose dysregulation is necessary to cause 
neoplastic growth in specific tissues (Kinzler, K.W et al., 1997). 
Gatekeepers include many classical tumor suppressors, such 
as RB1 and APC. Inactivation of both homologs of these genes, 
often through mutation of one copy and deletion of the second 
copy, is found both in hereditary forms of cancer and in the 
great majority of sporadic tumors of  the types seen in the 
hereditary disease. 
Another class of tumor predisposition genes, the ‘caretakers’ 
does not directly affect growth control. The loss of caretakers 
causes genomic instability and promotes mutation of 
gatekeepers and other genes directly involved in growth control. 
Mutations in caretakers, for example BRCA1-2 and HNPCC, 
are not often found in sporadic cancers. 
Tumors in Men1 arise through a two hit mechanism (Larsson et 
al., 1988) (Friedman E. et al., 1989) (Thakker  R.V., et al., 
1989).  Typically, loss of function of MEN1 occurs as a single-
base DNA change within MEN1 for a first hit and a large 
rearrangement of chromosome 11 for the second hit (Pannett 
A.A. et al, 2001) 
As mentioned above, this genetic mechanism of pathogenesis 
is typical of  classic tumor suppressor genes, as Rb or 
hereditary cancer genes involved in the maintenance of 
genomic integrity  as BRCA1 and HNPCC. 
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MEN1 is a tumor suppressor gene by several criteria: 
- First of all it has shown that Menin overexpression in tumor 
cells partially suppresses the tumor phenotype. Infact initial 
studies have revealed that menin overexpression inhibits the 
proliferation of Ras transformed fibroblasts (NIH3T3) in soft 
agar as well as the Ras induced tumor growth in nude mice 
(Kim Y.S. et al, 1999). 
- Most of the germline and somatic MEN1 mutations lead to 
protein truncation or absence. In this way the mutations cause 
“loss of function” of the gene, similar to the mutations of the 
most human tumor suppressor genes. 
- Loss of heterozigosity at 11q13 is evident in most of the 
tumors of MEN1 syndrome as well as in many sporadic tumors 
with a Men1 mutation in the other allele. 
- Complete loss of Menin has been identified by 
immunohistology in tumors from patients with Men1 or from 
mouse models of Men1. 
- Similar to knockout of the most human tumor suppressor 
genes tested in mice, homozygous loss of Menin causes death 
in mice in utero. 
- Furthermore mice with heterozygous Men1 loss gestate 
normally but after 9-16 months, they develop endocrine tumors 
similar to those observed in the human Men1 disease. 
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1.3 Menin interacts with several nuclear factors involved in 
transcription’s regulation 
 
The biological role of Menin in tumorigenesis remains unknown 
at this time. Protein database searches fail to demonstrate any 
protein sequences similar to Menin and therefore do not provide 
clues to its function. Unlike other tumor suppressor proteins 
such as p53, MEN1 disease-associated missense mutations 
are distributed along the length of the protein and therefore fail 
to reveal a specific site to focus study (Guo SS et al, 2001) 
Investigative efforts aimed to identify Menin’s function by 
studying interacting proteins have not resulted in a clear 
canonical biological pathway involving endocrine tumor 
development.  
To date, Menin has been found to interact with a variety of 
transcription factors, suggesting menin may regulate 
transcription (Figure 1). Among these proteins there are a 
series transcription factors involved in cell survival and 
apoptosis regulation such as JunD. JunD, which belongs to the 
AP1 family, and was the first Menin partner to be identified. 
Menin binds to the amino terminus of JunD (Agarwal S.K. et al., 
1999) and when overexpressed it inhibits JunD-dependent 
transcription. Although JunD does not promote cell proliferation 
and has been proposed to act as suppressor of cell growth 
(Pfard et al., 1994), in absence of menin expression it switchs 
from a growth suppressor to a growth promoter activity 
(Agarwal S.K. et.al., 2003), suggesting a possible of Menin 
induced tumorigenesis. 
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In addition to these studies, we have shown that Menin 
functions as a suppressor of MAPK induced phosphorylation of 
JunD, c-Jun without directly altering the activity of ERK and JNK 
kinases and the activity (Gallo A. et al., 2002). Besides, we also 
found that Menin overexpression repress serum-induced activity 
of the c-fos promoter, by down-regulating ERK-dependent 
transcriptional activity  of Elk1(Gallo A. et al., 2002). These 
findings suggest that Menin uncouples ERK and JNK activation 
from phosphorylation of their nuclear targets and inhibits the 
accumulation of Fos/Jun heterodimers. 
Menin is also necessary for the transcription of transforming 
growth factor ß-responsive genes, an activity mediated through 
a direct interaction of Menin and Smad3 (Kajii H.et al., 2001).  
While Menin does not influence Smad3-Smad4 dimerization or 
nuclear localization, it enhances Smad3 DNA binding and 
Smad3-mediated transcriptional activation. The finding that 
Menin is a key regulator of growth inhibitory signals arising from 
the activation of the transforming growth factor ß pathway 
strongly supports its role as a tumor suppressor. 
Menin also interacts with NFkB proteins involved in immune 
response, in cellular transformation and oncogenesis and it 
represses p65 mediated transcriptional activity (Heppner C. et 
al., 2001). 
Menin interacts with ASK (activator of S phase kinase) a 
component of cdc7/ASK kinase complex that is crucial in DNA 
replication and repair (Schnepp R.W. et al., 2004). Menin 
completely represses ASK induced cell proliferation. 
Besides, Menin is also involved in epigenetic regulation of 
transcription by associating with nuclear proteins involved in 
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chromatin modification. In fact Menin interacts with mSin3A, a 
subunit of histone deacetylase complex (Hyungsoo et al.,2003). 
Moreover a recent report has shown that Menin is associated 
with a Histone methyl transferase complex (HMTase complex) 
containing two trithorax family members: MLL2 and Ash2L. This 
complex can methylate H3 on Lys 4, an epigenetic mark 
associated with transcriptionally active chromatin (Hughes et 
al., 2004). 
In conclusion, a large number of studies suggest that Menin 
may control gene expression by interacting either with 
transcription factors or with histone modifying enzymes. In 
agreement with this model, Elledge and coworkers have shown 
Menin-dependent repression of human telomerase promoter, 
suggesting a potential mechanism through which Menin may 
inhibit the proliferation of tumor cells ( Lin S.Y. et al., 2003). 
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Figure 1    Menin interacts with several nuclear factors 
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1.4 Menin and the DNA damage response 
 
The identification of two further Menin-interactors, as 
Replication protein A (RPA) and the Fanconi Anemia protein 
FANCD2, both involved in multiple pathways of the DNA 
damage response, has brought up a potential role of the MEN-1 
gene in the maintenance of DNA integrity. 
FANCD2  is  a protein encoded by a gene mutated in patients 
with an inherited cancer prone syndrome, Fanconi Anemia. This 
syndrome is an autosomal recessive disorder charachterized by 
genomic instability and hematological cancers (D’Andrea et al., 
2003). Besides FA cells are hypersensitive to the cross-linker 
agent mytomycin C. However biallelic disruption of FANCD2 
results both in mytomycin and IR hypersensibility (D’Andrea et 
al., 2003). In response to IR, ATM phosphorylates FANCD2, an 
event that is required for S-phase checkpoint (Taniguchi et al., 
2002). Interestingly, FANCD2-Menin interaction is increased by 
γ –irradiation suggesting that these proteins cooperate in 
repairing DNA damage (Jin et al., 2003). 
The 32KDa subunit of RPA (RPA2), with which Menin interacts 
(Sukhodolets KE et al., 2003), is the homolog of SSB protein In 
Escherichia Coli. It is an heterotrimeric protein that binds 
ssDNA and it is required for DNA replication, recombination and 
repair.  
A further Menin-interacting protein involved in DNA replication 
and repair is ASK (activator of S phase kinase), a component of 
cdc7/ASK kinase complex (Schnepp R.W. et al., 2004). Menin 
interaction completely represses ASK induced cell proliferation. 
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To corroborate a potential role of Menin in maintaining genome 
integrity, it has been shown that Menin depletion leads to 
increased sensitivity to DNA damage, either in embryonic 
mouse fibroblasts or Drosophila larvae (Schnepp R.W. et al., 
2004) (Busygina V. et al., 2004). 
More recently, it has been shown that either Drosophila larvae 
or mouse embryonic fibroblasts lack of Menin expression iis 
linked to a deficiency for a DNA damage-activated S-phase 
checkpoint, through interaction suggesting with the forkhead 
transcription factor CHES1 (FOXN3), a component of a 
transcriptional repressor complex, that includes mSin3a, histone 
deacetylase 1 and 2 (Busygina V et al., 2006).  
Furthermore, Menin localizes to chromatin after UV irradiation  
in an ATR-CHK-dependent fashion (Farley S.M. et al., 2006). 
In addition to these recent findings, previous studies have 
associated MEN-1 syndrome with chromosomal instability 
(Tomassetti et al., 1995) and loss of DNA integrity (Hessman et 
al., 2001).  
In view of these observations I have decided to study the role of 
Menin in the DNA damage response and in particular in the 
DNA damage activated checkpoints 
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1.4   The cell cycle checkpoints 
 
To ensure survival and propagation of accurate copies of the 
genome on to subsequent generations, eukaryotic cells 
respond to  damaged or abnormally structured DNA by a 
multifaceted response that coordinates cell cycle progression 
with DNA repair, chromatin remodeling, transcriptional 
programs and other metabolic adjustments or cell death.  
The cell cycle checkpoints are defined as biochemical signalling 
pathways that sense various types of structural defects in DNA, 
or in chromosome function, and induce a multifaceted cellular 
response that activates DNA repair and delays cell-cycle 
progression (Zhou B.B. et al., 2000) (Nyberg, K. A. et al. 2002). 
These biochemical cascades include sensor proteins that 
monitor the genome for any abnormalities and help generate 
the signals that are amplified and propagated by 
adaptors/mediators and signal transducers to downstream 
checkpoint effectors that connect the checkpoints with the core 
cell cycle machinery (Zhou B.B. et al., 2000). To ensure faithful 
replication and transmission of the genome and to promote 
survival, checkpoints fulfil at least four tasks: they rapidly induce 
cell-cycle delay, help activate DNA repair, maintain the cell-
cycle arrest until repair is complete, and then actively re.initiate 
cell-cycle progression. Checkpoint malfunction leads to 
accumulation of mutations and chromosomal aberrations, which 
in turn increase the probability of developmental malformations 
or genetic syndromes and diseases including cancer. 
Most checkpoint pathways operate only in cycling cells, which 
are at higher risk of fixing and propagating deleterious 
 14
mutations. But even among proliferating cells, the choice of 
checkpoint cascade to be alarmed, and the outcome of such 
response, depends on many variables. These factors include 
the type, extent and duration of the DNA damage stimulus, the 
type of cell cycle, the cell type and differentiation stage, and the 
position of the cell within the cell cycle. 
In regard to cell cycle, we can  distinguish three different cell 
cycle checkpoints: G1 DNA damage checkpoint that arrests the 
cell cycle in G1 before DNA replication; S-phase DNA damage 
checkpoint that arrests the cell cycle in S-phase and G2 DNA 
damage checkpoint that blocks the cell cycle in G2 phase 
before mitosis (Lukas J. et al., 2004) (Shiloh Y. et al., 2003). 
During my PhD I have focalized my study on the function of 
Menin in the S phase checkpoint. This checkpoint is activated 
by genotoxic insults and causes only a transient and reversible 
delay in cell cycle progression, mainly by inhibition of new 
replica initiation and so slowing down DNA replication.  
The main sensors for S phase checkpoint are two proteins that 
belong to PIKK  (phosphatidil-inositol-3 kinase-like kinase) 
family: ATR (ATM and Rad3 related protein kinase) and ATM 
(ataxia teleangectasia mutated) (Abraham R.T.et al., 2001). 
In response to DSBs induced by ionizing radiations or chemical 
agents, there is the activation of ATM (Pandita T.K. et al., 
2000). ATM activated triggers two cooperating parallel 
cascades to inhibit the replicative DNA synthesis. ATM 
phosphorylates chk2 on thr 68. Activated chk2 induces, by 
phosphorylation, the ubiquitin mediated degradation of cdc25A 
phosphatase. ATM also initiates a second pathway by 
phosphorylating Nbs1: this protein was found in a complex with 
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two other genome maintenance proteins, Mre11 and Rad50 
(MRN complex) which plays an important role in the 
recombinational repair of DSBs (D’Amours D. et al., 2002) 
(Petrini, J. H. et al., 2003). This complex processes the termini 
of DSBs before initiation of strand invasion by Rad51. 
In contrast of ATM as a sensor of DSBs, when DNA is damaged 
by UV or chemicals that induce SSBs, the main DNA damage 
sensor is ATR. ATR binds to chromatin and it can bind  directly 
to UV induced lesions or to RPA coated single stranded DNA 
and it becomes activated. Active ATR phosphorylates chk1 
which delays cell cycle progression through S or G2 phases by 
inhibiting the Cdc25A and Cdc25C phosphatases (Bartek J. et 
al., 2004).  In this way it inhibits firing of replication origins.  
As for the ATM mediated checkpoint, ATR mediated pathway 
results in the phosphorylation of BRCA1 and Nbs1 that are 
implicated in homologous recombination mediated DNA repair.
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Figure 2     ATM and ATR mediated S-phase checkpoint 
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1.5 Double strand breaks and recombination-directed 
repair 
 
Maintenance of genome stability relies on the accurate repair of 
double strand breaks (DSBs) that arise during DNA replication 
or from DNA damaging agents. Failure to repair such breaks 
can lead to the introduction of mutations, chromosomal 
translocations, apoptosis and cancer. Hence, in order to 
preserve genome integrity, cells have evolved processes to 
respond and repair DSBs.  
In eukaryotes, DNA double strand breaks are repaired mainly 
by two distinct but interconnected pathways: non homologous 
end joining (NHEJ) and homologous recombination (HR) (Van 
Gent D.C. et al., 2001) (Khanna K.K. et al., 2001) (Valerie K. et 
al., 2003). 
Different studies have demonstrated that NHEJ is the 
predominant form of DSBs repair in G0/G1 cells while HR 
operates mainly during S and G2 phases (Essers J. et al., 
2000). The NHEJ pathway occurs between sequences with little 
or no sequence homology. 
During NHEJ, the two ends of a DSB are rejoined by simple 
ligation after little or no nucleolytic processing of the ends. In 
human this pathway involves the Ku70/80 heterodimer, DNA PK 
and the Lig4/Xrcc4 ligase.  
Since NHEJ is often accompanied by mutations and small 
deletions at the break-site, this pathway is generally considered 
error prone. 
 
 18
In mammalian cells, homologous recombination has emerged 
as the major mechanism for the error-free homology-directed 
repair of DSBs. In contrast to NHEJ, HR requires extensive 5’ 
resection to generate regions of single-stranded DNA at the 
break-site. The single stranded ends can subsequently invade a 
homologous template to prime DNA synthesis and copy and 
ultimately restore genetic information disrupted by the DSB 
(Figure 3). Since genetic information is preferentially copied 
from an intact sister chromatid, this pathway is error-free 
(Symington L.S. et al., 2002). 
Homologous recombination involves the exchange of DNA 
between sequences of perfect or near perfect homology over 
several hundreds of base pairs. The process of homologous 
recombination plays essential roles in the mitotic and meiotic 
cell cycles of most eukaryotic organisms. It is now widely 
recognized that the primary function of homologous 
recombination in mitotic cells is to repair doublestrand breaks 
(DSBs) that form as a result of replication fork collapse, from 
processing of spontaneous damage, and from exposure to 
DNA-damaging agents. In mammalian cells faulty repair of DSB 
compromises tissue and organ function, and favours the 
development of cancer and degenerative diseases. 
The double strand break (DSB) repair model provides a 
prototypic molecular mechanism for homologous recombination. 
It consists of (Figure 3):  
1) introduction of the DSB 
2) processing of the DSB to produce tailed DNA with 3’-ssDNA 
overhang 
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3) invasion of one ssDNA end into homologous dsDNA 
4) subsequent invasion or annealing of the other processed end 
5) DNA synthesis and ligation to form double Holliday junctions 
6) branch migration and resolution of the double Holliday 
junctions. 
 
The proteins participating in the DSB repair pathways are highly 
conserved from yeast to humans, as in the nuclear organization 
of the repair processes. 
In humans, efficient HR requires replication protein A (RPA) and 
the proteins of the Rad52 group including the 
Mre11/Rad50/Nbs1 (MRN) complex. Proper DNA damage 
checkpoint activation requires the MRN complex, Rad17, 
Rad9/Hus1/Rad1 and ATR/ATRIP complexes and ATM, as well 
as a number of adaptor proteins including BRCA1 and claspin, 
and effector kinases Chk1 and Chk2.  
The central activity of HR is conferred by the Rad51 protein, a 
eukaryotic homolog of the Escherichia coli RecA recombinase, 
which catalyses the invasion of the broken ends of the DSB into 
the intact sister chromatid. Human Rad51 is a relatively small 
protein (38 Kda). It is functional as a long helical polymer, made 
of hundreds of monomers, that wraps around the DNA to form a 
nucleoprotein filament. The relevance of Rad51 in the HR is 
underlied by the observation that cells deficient in Rad51 
accumulate DSBs after replication or at stalled replication forks 
(Sonoda E et al., 1998).  
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Figure 3 Double-strand break/recombinational repair.  
Double-strand breaks are repaired by either homologous 
recombination, which in eukaryotes depends on the Rad51-
family proteins, or by nonhomologous end-joining mediated by 
the DNA-PK complex. A key intermediate in homologous 
recombination is the Holliday intermediate, in which the two 
recombining duplexes are joined covalently by single-strand 
crossovers. 
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2.   RESULTS 
 
 
2.1 Menin overexpression promotes the phosphorylation of 
Chk1 and Chk2 in response to etoposide 
 
ATM and ATR kinases are central component of the DNA 
damage response. Upon DNA damage, they activate a network 
of damage-response pathways by phosphorylating cellular 
target proteins that activate DNA repair pathways and cell cycle 
checkpoints. Among these downstream effectors, activated 
checkpoint kinases Chk1 and Chk2 lead to cell cycle block by 
inhibiting the CdK2/Cdc7-Cdc45 cascade that is required for 
assembling of pre-replication complexes (Sancar A. et al., 
2004). 
I have investigated the effect of Menin over-expression on the 
ATM/ATR dependent phosphorylation of Chk1, Chk2 and other 
proteins involved in the activation of checkpoints, in response to 
etoposide. Etoposide is an inhibitor of toposoimerase II, causing 
first the accumulation of DNA double strand breaks (DSB), and 
later the generation of DNA single breaks (SSB). Chk1 is mainly 
activated by ATR in a SSB-dependent fashion, while Chk2 is 
mainly activated by ATM in a DSB-dependent fashion .  
To this aim I have transiently transfected Hela or H-293 cells 
with either an empty vector or a Menin expressing vector.  
After transfection, cells were treated with etoposide at 
5micromol concentration for different time points, as indicated in 
 22
As shown in figure 4, Menin overexpression promoted Chk1 
phosphorylation in response to etoposide already after 0,5 hr of 
treatment as compared with the control and the activation was 
kept on for two hours.  
Similarly, in HEK 293 cells Menin overexpression anticipated 
the induction of Chk1 phosphorylation by etoposide without 
affecting its duration time. To at less extent, Menin 
overexpression also increased Chk2 phosphorylation. 
Furthermore, Menin overexpression doesn’t influence the 
etoposide-induced autophosphorylation of ATM on serine 1981 
or of H2AX (data not shown), ruling out the possibility that it 
may increase the rate of DNA damage 
ATR-mediated activation of Chk1 requires RPA-dependent 
recruitment of Rad17 and Rad9 complexes at the DNA-
damaged sites (Zou L. et al., 2005). Since Menin has been 
shown to interact with RPA (Sukhodolets K. E. et al., 2003) I 
investigated whether Menin regulates the recruitment of Rad17 
and Rad9 complexes at the site of DNA damage.  
As shown in the Figure 5 (panel B), Menin over-expression had 
no effect on either Rad17 or Rad9 retention to chromatin. 
Similarly, Menin had no effect on etoposide induced 
phosphorylation of RPA or p53 (Figure 5, panel A). 
These findings suggest that increased levels of Menin 
expression specifically promotes Chk1 phosphorylation in 
response to DNA damage, rather than enhancing overall 
activation of ATM or ATR dependent pathways,  
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Figure 4 Menin overexpression promotes the 
phosphorylation of Chk1 and Chk2 in response to 
etoposide but doesn’t influence ATM activation. 
To analyse the effect of Menin overexpression on the ATM/ATR 
mediated pathways, H-293 and Hela cells were transfected 
either with an empty vector or with a Menin-encoding vector. 24 
hrs after the transfection cells were treated with 5 micromol 
etoposide and western blot analysis were performed with the 
indicated antibodies. 
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Figure 5   Menin overexpression  has no effect on the 
activation  of RPA, p53,  Rad9 and Rad17 proteins  
Hela cells were treated with etoposide and A) whole extracts 
and B) fractionated extracts were analyzed by western blot 
performed with the indicated antibodies. Has shown in the 
figure Menin doesn’t influence the activation of other proteins 
involved in the DNA damage checkpoints. 
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2.2 Menin overexpression promotes the phosphorylation 
of Chk1 and Chk2 in S-phase arrested cells 
 
To distinguish between G1 and S-phase checkpoint we 
assessed the effect of Menin overexpression in Hela cells that 
were arrested in S-phase by double thymidine block, and then 
treated with etoposide for different time points after release of 
thymidine.  As shown in the figure, Menin significantly anticipate 
Chk2 phosphorylation suggesting that it affects S-phase 
checkpoint. At a least extent Menin also affected Nbs1 and 
Chk1 phosphorylation.   
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Figure 6   Effect of Menin in S phase arrested cells 
  Hela cells were synchronized at the beginning of S phase by 
double thymidine block: 24 h incubation with 1 mM thymidine, 
an interval of thymidine-free incubation for 8 h, and second 
thymidine incubation for 14 h. The cells were treated with 
etoposide and western blot analysis were performed with the 
indicated antibodies. 
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2.3 Stable Menin overexpression promotes and protracts 
the activation of S-phase checkpoint 
 
To further study the effect of Menin on Chk1 and Chk2 
phosphorylation we generated HEK-293 cell lines stably 
overexpressing Menin. As shown in the Figure 7  three different 
HEK-293 clones overexpressing Menin showed enhanced 
phosphorylation of Chk1, but not Chk2, when treated with 
etoposide. HEK-293/MenHa clones 3 and 10, were further 
analysed to investigate the effect of Menin over-expression on 
the extension time of Chk1 and Chk2 phosphorylation after 
removal of etoposide. As shown in figure, in the control cell line 
etoposide-induced phosphorylation of Chk1 was turned on 1 
hour after the treatment and disappeared after removal of the 
drug, while Chk2 phosphorylation was detectable already at 30 
minutes and remained on after removal of the drug. 
Presumably, the different kinetic of Chk2 and Chk1 
phosphorylation reflects the different kinetic of DSB and SSB 
accumulation and consequently the different kinetic of DSB 
mediated activation of ATM and the SSB-mediated activation of 
ATR. Interestingly in MenHa-clone 3 the kinetic of Chk1 
phosphorylation was similar to that of Chk2. In contrast, neither 
H2AX or ATM phosphorylation changed (data not shown), 
indicating that Menin over-expression did not cause DNA 
damage. All the data discussed above, were obtained also with 
MenHa clone 10 (data not shown). These results suggest that 
Menin might induce ATM-mediated phosphorylation of Chk1. 
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Figure 7   Menin protracts Chk1 phosphorylation in 
response to etoposide treatment  
H-293 clones stably expressing HA-tagged Menin, or  the 
control pcDNA3.1 empty vector, were treated either with 
etoposide for 0.5 or 1 hour, as indicated. Western blot analysis 
were performed with the indicated antibodies. As shown Menin 
overexpression promotes the phosphorylation of both Chk1 and 
Chk2 in response to etoposide (panel A). HEK 293/MenHA 
clones were further analysed to investigate the effect of Menin 
overexpression on the extension time of Chk1 and cHk2 
phosphorylation after removal of etoposide. As shown (panel B) 
in the control cell line etoposide-induced phosphorylation of 
Chk1 was turned on 2 hrs after the treatment and disappeared 
after removal of etoposide, while Chk2 phosphorylation was 
detectable already at 30 minutes and remained on after 
removal of the drug.  
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2.4   Menin overexpression doesn’t influence the cell cycle 
 
Subsequently I have investigated the functional significance of 
protracted Chk1 phosphorylation. To this aim I have examined 
the cell cycle distribution of control and MenHA overexpressing 
clones in presence or absence of etoposide by FACS analysis. 
Control cells and MenHA clone3 were treated with etoposide for 
4 hours and collected after 24 and 48 hours from  removal of 
the drug. As shown in these FACS panels (Figure 8), Menin 
overexpression doesn’t influence the cell cycle distribution, 
suggesting that the overexpression of Menin may affect a chk1 
function different that S-phase arrest. 
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Figure 8  Cell cycle analysis of Menin overexpressing 
clones  
The cell cycle distribution of control and MenHA clones was 
examined in presence or absence of etoposide with FACS 
analysis. To this aim  control cells and MenHA clone3 were 
treated with etoposide for 4 hours and collected after 24 and 48 
hours from  removal of the drug. As shown in these FACS 
panels, Menin overexpression doesn’t influence the cell cycle 
distribution, suggesting that the overexpression of Menin may 
affect a Chk1 function different that S-phase arrest. 
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2.5 Menin overexpression increases the rate of 
homologous-directed DNA repair  
 
Homologous recombination, the exchange of DNA sequence 
between homologous DNA molecules, is essential for accurate 
genome duplication and preservation of genome integrity. DNA 
double-strand breaks (DSBs) and single-stranded gaps are 
efficient initiators of homologous recombination, which results in 
their accurate repair using an intact homologous template DNA 
in the same cell (Symington L.S. et a., 2002). Recent studies 
indicate that HR is a prominent DSBs repair pathway in 
mammalian cells.  
In mammals, at least, the recombination machinery is subject to 
regulation by tumor suppressors. In somatic cells this provides 
a correlation between homologous recombination and the 
maintenance of genome stability to safeguard against genome 
rearrangements and ultimately for cancer prevention. 
As mentioned above Menin interacts with FANCD2, that is 
involved in HR through its interaction with the BRCA1 pathway. 
Furthermore a recent report has established that Chk1 is a key 
regulator of genome maintenance by the HR system (Sorensen 
CS et al., 2005). As showed above, in spite of the protracted 
phosphorylation of Chk1 I have found that neither the rate of 
etoposide-induced cell cycle arrest nor apoptosis were changed 
in Menin overexpressing clones. This observation suggests that 
the overexpression of Menin may affect a Chk1 function 
different than S-phase arrest. 
To analyze the functional significance of the effect of Menin 
overexpression on Chk1 phosphorylation, I have investigated 
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the involvement of Menin on HR system performing a 
fluorescence based assay. To this aim I have used a 
recombination reporter system performed by M. Jasin 
(Memorial Sloan Kettering Cancer Center, New York) which 
contains two differentially mutated GFP genes oriented as direct 
repeats and separated by a drug selection marker, the 
puromycin N-acetyltransferase gene (Figure 9). The first GFP 
gene, at the 5’ end, contains the recognition site for Sce-I, a 
rare cutting endonuclease (Colleaux L., 1998 ), which doesn’t 
cleave several eukaryotic genomes tested (Jasin M., 1996).  
The Sce-I site was incorporated into a Bcg-I restriction site, 
present in the functional GFP gene, by substituting 11 bp of wild 
type gene. These substituted base pairs also supply two in 
frame stop codons, which terminate translation and inactivate 
the expression of GFP.  
The second gene contains a Bcg site (canonic site in GFP 
sequence), a small deletion at amino terminal domain and one 
at carboxy terminal domain, it doesn’t contain a promoter and it 
is no functional. Furthermore this gene will undergo DSBs when 
Sce-I is expressed in vivo by transfection. 
This system was stably integrated in Hela cell line (kindly 
provided by Prof. V.E. Avvedimento) and DSB is then induced 
by transient transfection of a plasmid expressing Sce-I 
endonuclease.  
Repair of DSBs by HR leads to a functional GFP gene, allowing 
to score the gene conversion events by flow cytometry.  
To analyze the effect of Menin on homologous recombination 
directed repair I have transfected different Hela /DR-GFP 
clones with Sce-I expressing plasmid in presence or in absence 
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of Menin and after 7 days the cells were analyzed for HR 
efficiency by flow cytometry. As shown in the Figure 10 
coexpression of Menin and Sce significantly increases the gene 
conversion events expressed as GFP positive cells compared 
with the control. Furthermore I have analyzed genomic DNA 
extracted by the same cells, by performing PCR reactions using 
a fixed 3’ primer together with 5’Sce oligo or with a 5’Bcg oligo. 
As shown in the figure, Menin overexpression increases also 
the genomic DNA levels.  
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Figure 10  Menin increases the rate of homologous-
directed DNA  
Different Hela /DR-GFP clones were transiently transfected with 
a I-SceI expressing plasmid in presence or in absence of Menin 
and after 7 days were analysed for HR efficiency by flow 
cytometry. As shown coexpression of Menin significantly 
increased the number of GFP positive cells so Menin increases 
the homologous recombinational events. Below are reported 
also the PCR analysis of genomic DNA extracted by the same 
cells. 
 
 
 36
3. DISCUSSION 
 
 
Patients affected by Men1 develop multiple primary tumors in 
the parathyroids, the endocrine pancreas, and the anterior 
pituitary (Marx SJ, 2002). Also, the Men-1 syndrome has been 
associated with chromosomal instability (Tomassetti et al., 
1995). Besides, many patients also develop tumors in a range 
of non-endocrine tissues, suggesting that MEN1 may control 
tumor development in different tissues, depending on genetic 
interactions with other cancer-associated genes. Menin, the 
nuclear protein encoded by the MEN1 gene, interacts with a 
large number of proteins, however the precise biochemical 
function of Menin mediating its tumor-suppressor activity has 
yet not been established. The identification of two novel Menin-
interactors, Replication protein A (RPA) (Sukhodolets KE et al., 
2003) and the Fanconi Anemia protein FANCD2 (D’Andrea et 
al., 2003) both involved in multiple pathways of the DNA 
damage response (Zou L. et al., 2003), has brought up a 
potential role of the MEN-1 gene in the maintenance of DNA 
integrity.  In the same direction, previous studies have 
associated the MEN-1 syndrome with chromosomal instability 
and loss of DNA integrity (Ikeo Y. et al., 2000) (Tomassetti  P. 
et al., 2005). Furthermore, extensive chromosomal breakage 
has been observed in lymphocytes from MEN1 patients but not 
in lymphocytes from normal individuals, after treatment with an 
agent cross-linking doublestrand DNA (Itakura Y. et al., 2000). 
A  genome-wide LOH screening of 13 MEN1 patients indicates 
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that MEN1 pancreatic tumors fail to maintain DNA integrity and 
chromosomal stability (Hessman O. et al., 2001). 
Also, Menin depletion leads to increased sensitivity to DNA 
damage, either in embryonic mouse fibroblasts or Drosophila 
larvae (Jin S. et al., 2003) (Busygina V. et al., 2004).   
In my thesis work I have accumulated evidence suggesting that 
Menin functions in the DNA damage pathway by regulating the 
activation of the essential checkpoint kinase Chk1 and the 
frequency of homologous-directed DNA repair. 
DNA damage induced by radiations, chemical agents, or 
oxidative stress elicits a complex array of checkpoint pathways 
that result in the onset of cell cycle delay, DNA repair, 
chromatin remodelling, modulation of transcriptional programs, 
and the optional triggering of cell death (Zhou B.B. et al., 2000) 
(Nyberg, K. A. et al. 2002). Central to these processes are ATM 
(ataxia teleangectasia mutated), ATR (ATM related) and DNA-
PK kinases. Upon DNA damage ATM and ATR activate a 
network of damage-response leading to activation of the 
checkpoint kinases Chk1 and Chk2 and DNA repair proteins, 
while DNA-PK is involved in Non-Homologous-End-Joining 
(NHEJ) repair. The inability to respond properly to DNA damage 
leads to genetic instability and in turn cancer. Furthermore, 
early in the progression of major human cancer types  (before 
genomic instability and malignant conversion) tumorigenic 
events activate the ATR/ATM-regulated checkpoint through 
deregulated DNA replication and DNA damage. Chk1 and Chk2 
are essential for S-phase delays after DNA damage.   
Besides, Chk1 is required for homologous recombination repair 
(Sorensen CS et al., 2005). Several studies have indicated IR 
 38
and double strand breaks activate the ATM/Chk2 damage 
pathway, while UV light, single strand breaks (SSB) and 
blocked DNA replication activate the ATR/Chk1 pathway 
However, accumulating evidence indicate that ATM and ATR 
can be activated by overlapping damaging agents, but yet they 
maintain the specificity of their substrates. Accordingly, UV-
activated ATM specifically phosphorylates Chk2, while IR-
activated ATR specifically activates Chk1. Presumably, the 
substrate specificity is coordinated by the unique binding and 
activation of ATM and/or ATR with auxiliary proteins at sites of 
DNA.  
I have investigated the DNA damage response of embryonic 
kidney cell H-293, stably over- expressing menin. Normally, H-
293 cells respond to etoposide, an inhibitor of toposoimerase II 
causing accumulation of both DSBs and SSBs, by activating 
first the ATM-Chk2 pathway and subsequently the ATR-Chk1 
pathway. Inversely, UV leads first to activation of ATR-Chk1 
and later ATM-Chk2. In both cases Chk1 activation is transient, 
disappearing shortly after removal of the DNA-damaging agent. 
Conversely, Chk2 activation persists after removal of either 
agents. Presumably, the fast decay of Chk1 activation is the 
result of ubiquitin-dependent degradation of active Chk1, once it 
translocates from chromatin to nucleoplasm (Zhang YW et al., 
2005).  
I found that stable expression of Menin prolongs the time-
course of etoposide or UV-induced phosphorylation of Chk1, 
without affecting either the ATR pathway or the rate of DNA 
damage.  
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My results suggest that Menin promotes and prolongs the time-
course of Chk1 phosphorylation induced by etoposide. In spite 
of the protracted phosphorylation of Chk1,  I found that the rate 
of etoposide-induced cell cycle arrest nor apoptosis were 
changed in MenHa overexpressing clones. This observation 
suggests that the overexpression of Menin may affect a Chk1 
function different that S-phase arrest.  
Recent studies have shown that Chk1 is required for 
homologous recombination repair through the activation of the 
essential recombination repair protein rad51 (Sorensen CS et 
al., 2005). Interestingly, I have observed that Menin 
overexpression increases the efficiency of homologous-directed 
DNA repair (HDR) of DSBs, suggesting that that this effect  
might be a direct consequence of the sustained activation of 
Chk1, itself involved in this mechanism of DNA repair. 
Several studies indicate that HR is a prominent DSBs repair 
pathway in mammalian cells. In mammals, at least, the 
recombination machinery is subject to regulation by tumor 
suppressors. Homologous recombination, the exchange of DNA 
sequence between homologous DNA molecules, is essential for 
accurate genome duplication and preservation of genome 
integrity. DNA double-strand breaks (DSBs) and single-
stranded gaps are efficient initiators of homologous 
recombination, which results in their accurate repair using an 
intact homologous template DNA in the same cell (Symington 
L.S. et a., 2002). In somatic cells this mechanism provides a 
correlation between homologous recombination and the 
maintenance of genome stability to safeguard against genome 
rearrangements and ultimately for cancer prevention. 
 40
Besides, although Menin is ubiquitously expressed, its 
expression level is particularly high in the testis, consistent with 
a potential role in recombination (Stewart C. et al, 1998). 
Hence, my current findings are consistent with the idea that 
processes involved in the maintenance of protein integrity may 
be important for ensuring the integrity of the genome and also 
they are consistent with the notion that DNA repair might be one 
of the functions of Menin and suggest an additional mechanism 
by which Menin functions as a tumor suppressor by promoting 
and protracting the phosphorylation of Chk1 during DNA 
damage response. 
The inability to respond properly to DNA damage leads to 
genetic instability, which in turn may enhance the rate of cancer 
development.  Indeed, tumor suppressor genes as p53, ATM 
and BRCA1-2 have been linked to DNA-damage response, and 
more accumulating evidence are connecting this cellular 
response with tumorigenesis. However, mutations in some 
tumor suppressor genes, as BRCA1 and BRCA2, only 
predispose to breast and ovarian cancers. Therefore a key 
issue is to assess the cell-type and tissue-specific differences of 
DNA damage response pathways. Understanding how Menin 
influence Chk1 activation and DNA repair will contribute to 
expand the knowledge of these pathways and facilitate the 
development of more specific and effective anticancer 
therapies.   
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4. MATERIALS AND METHODS 
 
 
4.1 Cell culture 
HEK 293, Hela and Hela Dr-GFP (stable cell line) were grown 
respectively in complete Dulbecco’s modified Eagle’s medium 
(DMEM) or RPMI supplemented with 10% Fetal Bovine Serum 
(Invitrogen). The cells also received 1% L-glutamine, and 1% 
penicillin–streptomycin and were housed in an incubator 
maintaining an atmosphere of 90% of humidity and 5.0 CO2 at 
37°C. All cell samplings for preparation of DNA, RNA and 
proteins were performed on cells cultured to a confluency of 
80%. 
 
4.2 Stable and transient transfection 
The plasmids used for the transfections were: pcDNA 3.1 Men-
HA (obtained using standard cloning techniques), pCβASce and 
pcDNA 3.1 HA as a control vector. These constructs were 
transfected to HEK 293, Hela and Hela DR-GFP cells according 
to Lipofectamine and Lipofectamine 2000 reagent protocols 
(Invitrogen). Stable transfectants were selected in gentamycin 
(Calbiochem) at a concentration of 800 microgr/ml. I clonally 
expanded three different clones named M3, M10 and M11. 
Furthermore HEK 293 cells were transfected with pCDNA 3.1 
HA without insert (control vector). After clonal expansion, 
transfectants were cultured in the presence of 400 microgr/ml of 
gentamycin and used at passages 4 and 5. 
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4.3 Cell synchronization 
Hela cells were synchronized at the beginning of S phase by 
double thymidine block and release protocol: first 24 h 
incubation with 1 mM thymidine, an interval of thymidine-free 
incubation for 8 h, and second thymidine incubation for 14 h. 
 
4.4  Drug treatment 
Etoposide (Calbiochem) was dissolved in dimethyl sulphoxide 
(DMSO) and it was additioned  at 5 micromol concentration to 
the cells after 24 hours of transfection. Aliquots were prepared 
in DMSO and stored at -20°C.  
 
 4.5 Cell extracts preparation and Western blot analysis 
To detect protein expression, I have prepared whole and 
fractionated cell lysates. The cells were collected by screaping 
and washed twice in PBS 1X. The whole cell lysates  were 
prepared from freshly isolated cells by using lysis buffer (250 mM 
sucrose, 20mM TrisHCl, 1,1 mM MgCl2, 0,2% Triton, 250 mM 
NaCl) supplemented with protease inhibitor mixture 
(Calbiochem), PMSF and sodium orthovanadate as phosphatese 
inhibior. The cells were incubated in ice for 15 minutes and 
centrifuged at 13000 rpm for additional 15 minutes. Chromatin 
fractionations were performed essentially as described by Zou 
and Elledge (Zou L. et al., 2002). Briefly, the cells are 
resuspended in 200 µL of solution A (10 mM HEPES at pH 7.9, 
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 
1mMDTT, 10mMNaF, 1mMNa2VO3, protease inhibitors). Triton 
X-100 was added to a final concentration of 0.1%, and the cells 
were left on ice for 5 min. Cytoplasmic proteins (S1) were 
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separated from nuclei (P2) by lowspeed centrifugation (1300g for 
4 min). Isolated nuclei were washed once with solution A and 
lysed in 200 µL of solution B (3 mM EDTA, 0.2 mM EGTA, 1 mM 
DTT). After a 10-min incubation on ice, soluble nuclear proteins 
(S2) were separated from chromatin (P2) by centrifugation 
(1700g for 4 min). Isolated chromatin was washed once with 
solution B and spun down at high speed (10,000g for 1 min). 
Finally, chromatin was resuspended in 200 µL of SDS sample 
buffer. The protein concentration from supernatants was 
determined by Biorad assay. Protein samples was separated in 
10% Tris-glycine SDS/PAGE gels, transferred to nitrocellulose 
membranes, and hybridized with appropriate antibodies. Blots 
were developed by enhanced chemiluminescence (Roche). 
 
4.6 Antibodies 
Menin C-19 (#sc-8200, santa cruz), pChk1-Ser 345 (#2341, cell 
signaling),  Chk1 tot (#sc-8408, santa cruz), pChk2 (#2668,      
cell signaling), Chk2 tot (#sc-8813, santa cruz), Rad17 (#12416, 
santa cruz),  pP53 Ser 15 (#9284, cell signaling),  pRPA Ser 4/8 
(#A300-245A, bethyl), Erk 1-2 (#sc 153, santa cruz), pNbs1 Ser 
343 (#3001, Cell Signaling), pATM Ser 1981 (#4526, cell 
signaling), Tubulin (#sc 8035, santa cruz).  
 
4.7 RNA and DNA extraction 
Total RNA was extracted using Triazol (Gibco BRL) method. 
Genomic DNA extraction was performed with following protocol: 
cellular pellet was resuspended in 10mM Tris pH 7.8 and 50mM 
NaCl solution. After addiction of 1% SDS the sample was gently 
mixed. Proteinase K, at the final concentration of 20 microgr/ml, 
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was added and the sample incubated at 55% over night. The 
day after,  hot NaCl at the final concentration of 1.5 M was 
added and DNA was extracted by phenol/chloroform. The DNA 
was precipitated by adding ethanol, the pellet was dried and 
resuspended in TE buffer. 
 
4.8  PCR analysis 
cDNA was synthesized in a 20 microl reaction volume 
containing 2 micrograms of total RNA, 4 units of Omniscript 
Reverse Trascriptase (Quiagen), 1 microl random examer [20 
ng/microl] (Invitrogen). 
mRNA was reverse transcribed for 1 hr at 37°C and the 
reaction was heat-inactivated for 10 minutes at 70°C. The 
products were stored at -20°C until use. PCR analysis was 
performed in a 50 microl reaction mixture containing 2 microl of 
synthesized cDNA product or 1 microgr of genomic DNA, 5 
microl of 10X PCR buffer, 1,5 mM MgCl2, 0,3 mM dNTP, 1,25 
unit of Taq polymerase (Roche) and 6 micromol of each primer. 
The primer sequences that were used for the different mRNAs 
or DNAs were: 
5’SceI GCTAGGGATAACAGGGTAAAT 
5’ Bcg GAGGGCGAGGGCGATGCC 
3’ Common TGCACGCTGCCGTCCTCG that amplify a 
fragment of 443 base pairs 
Beta-actin/R AAAGCCATGCCAATCTCATC 
Beta-actin/L GATCATTGCTCCTCCTGAGC that amplify a 
fragment of 250 bp 
Amplifications were performed in a Primus termocycler (MWG-
Biotech) using the following program:  
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95°C 5 min x 1 cycle 
95°C 45 sec 
57°C 30 sec 
72°C 2 min x 30 cycles 
72°C 10 min x 1 cycle 
The number of cycles were selected and validated by running 
several control reactions and determining the linear range of the 
reaction. 15 microl of the PCR products were applied on a 1.2% 
agarose gel and visualized by ethidium bromide staining. 
Densitometric analysis was performed using phosphor-imager. 
The determination for each point was carried out on at least 3 
independent reactions. 
 
4.9 Fluorescence activated cell sorter  (FACS) analysis 
Hela DR-GFP cells were transfected with pcDNA 3.1/MenHA or 
control plasmid in presence or absence of pCβASce  and after 
six days were treated with tripsyn and collected. The cells were 
washed twice in cold PBS 1x and after they were resuspended 
in 500 microl of PBS 1X . 6X104 cells were analyzed.  
 
4.10  Cell cycle analysis 
To perform a cell cycle analysis I have used a propidium iodide 
staining.  The cells were harvested and washed, after they were 
fixed in ice-cold 70% ethanol while vortexing. Susbsequently 
the cells were centrifuged at 2000rpm for 5 minutes and 
washed twice in PBS. After a treatment with 1mg/ml 
ribonuclease for 5 minutes at room temperature, 40µl propidium 
iodide (50µg/ml) was added to the cells and they were analyzed 
by flow cytometry 
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